American Oncology Network, Inc. (AONC)

USD 6.5

(8.15%)

EBITDA Summary of American Oncology Network, Inc.

  • American Oncology Network, Inc.'s latest annual EBITDA in 2023 was -39.35 Million USD , down -98.87% from previous year.
  • American Oncology Network, Inc.'s latest quarterly EBITDA in 2024 Q2 was -8 Million USD , up 120.48% from previous quarter.
  • American Oncology Network, Inc. reported an annual EBITDA of 23.08 Million USD in 2022, up 194.02% from previous year.
  • American Oncology Network, Inc. reported an annual EBITDA of 7.85 Million USD in 2021, down -69.73% from previous year.
  • American Oncology Network, Inc. reported a quarterly EBITDA of -8 Million USD for 2024 Q2, up 120.48% from previous quarter.
  • American Oncology Network, Inc. reported a quarterly EBITDA of -2.72 Million USD for 2023 Q3, down -81.93% from previous quarter.

Annual EBITDA Chart of American Oncology Network, Inc. (2023 - 2020)

Historical Annual EBITDA of American Oncology Network, Inc. (2023 - 2020)

Year EBITDA EBITDA Growth
2023 -39.35 Million USD -98.87%
2022 23.08 Million USD 194.02%
2021 7.85 Million USD -69.73%
2020 25.94 Million USD 0.0%

Peer EBITDA Comparison of American Oncology Network, Inc.

Name EBITDA EBITDA Difference
ATI Physical Therapy, Inc. 82.86 Million USD 147.487%
Assure Holdings Corp. -19.82 Million USD -98.502%
Novo Integrated Sciences, Inc. -5.84 Million USD -572.782%
Panamera Holdings Corporation -7.12 Million USD -452.631%